Background: Within influenza vaccine effectiveness (VE) studies at primary care level with a laboratory-confirmed outcome, clinical case definitions for recruitment of patients can vary. We used the 2022-23 VEBIS primary care European multicentre study end-of-season data to evaluate whether the clinical case definition affected IVE estimates.
Methods: We estimated VE using a multicentre test-negative case-control design.
Background: Decarbonisation of the European economy is one of the main strategic goals of energy transition in the European Union (EU), which aims to become a leader in this process by 2050 and to include other European countries making thus the European continent the first carbon neutral region in the world. Although decarbonisation is an important goal of the EU, the models for monitoring the progress of this process have not yet been clearly defined, and views on the social, economic, and security implications in terms of prioritising decarbonisation are conflicting. The main objective of this paper is to determine the methodological correctness of the existing method of decarbonisation monitoring, to develop a new monitoring model indicating the differences in the EU and European countries that are non-EU and to point out the underlying social, economic and security implications that must certainly find their place in the decision-making process in this field.
View Article and Find Full Text PDFIntroduction: The aim of our study was to examine the scabies incidence in the Croatian population and to analyse potential related factors.
Methods: This mixed ecological study is based on a retrospective medical record review. National data from communicable disease reports was sourced and analysed for an 11-year period (2007-2017), with more focus on the period 2014-2017.
Understanding the country-specific epidemiology of disease, which may vary greatly among countries, is crucial for identifying the most appropriate preventive and control measures. An overview of the local epidemiology of viral hepatitis in Croatia is given in this paper. The overall prevalence of hepatitis B in Croatia is low (less than 2% HBsAg carriers in the general population).
View Article and Find Full Text PDF